Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(2.96)
# 1,379
Out of 5,150 analysts
885
Total ratings
39.56%
Success rate
0.52%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LXRX Lexicon Pharmaceuticals | Maintains: Buy | $4 → $6 | $1.72 | +248.84% | 24 | Mar 5, 2026 | |
| QTTB Q32 Bio | Initiates: Buy | $13 | $4.54 | +186.34% | 1 | Feb 25, 2026 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $231 → $239 | $201.35 | +18.70% | 23 | Feb 24, 2026 | |
| FBIO Fortress Biotech | Reiterates: Buy | $17 | $3.05 | +457.38% | 5 | Feb 23, 2026 | |
| ARMP Armata Pharmaceuticals | Maintains: Buy | $9 → $15 | $10.80 | +38.89% | 16 | Feb 23, 2026 | |
| ANL Adlai Nortye | Upgrades: Buy | $16 | $8.66 | +84.86% | 5 | Feb 13, 2026 | |
| APRE Aprea Therapeutics | Maintains: Buy | $5 → $4 | $0.93 | +332.25% | 16 | Jan 29, 2026 | |
| CALC CalciMedica | Downgrades: Neutral | n/a | $0.60 | - | 13 | Jan 29, 2026 | |
| TPST Tempest Therapeutics | Upgrades: Buy | $11 | $2.35 | +368.20% | 20 | Jan 22, 2026 | |
| KURA Kura Oncology | Reiterates: Buy | $40 | $8.25 | +384.85% | 29 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 → $310 | $257.15 | +20.55% | 35 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $136 | $61.47 | +121.25% | 51 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.40 | +400.00% | 1 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $0.74 | +305.41% | 20 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $97 | $26.33 | +268.40% | 25 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $7 | $4.60 | +52.17% | 3 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $60 | $25.20 | +138.10% | 27 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.49 | +1,521.73% | 3 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $6 | $4.90 | +22.45% | 19 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $27.57 | +70.48% | 6 | Nov 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $6.00 | +333.33% | 18 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $1.87 | +381.28% | 13 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $0.65 | +2,194.63% | 33 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $9 | $4.35 | +107.13% | 30 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $52 | $29.74 | +74.85% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $29.51 | +93.15% | 27 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $102 | $30.73 | +231.92% | 35 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.20 | +1,992.05% | 17 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.90 | +451.72% | 30 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.90 | - | 26 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.23 | +254.61% | 17 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $42 | $29.19 | +43.88% | 36 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $30 | $30.73 | -2.38% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $9.05 | +10.56% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.58 | - | 23 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $29.09 | +44.38% | 1 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.16 | +1,112.12% | 2 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.23 | +225.20% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $2.29 | +4,266.81% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $3.15 | +90.78% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $2.86 | +809.09% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $280 | $2.43 | +11,422.63% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $1.02 | +1,566.67% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $8.00 | +300.00% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.16 | +5,539.10% | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.36 | +1,223.53% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $5.77 | +315.94% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.39 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $5.46 | +467.77% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.63 | +1,812.66% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $15.63 | +136.72% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.86 | +491.40% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $21.70 | -67.74% | 29 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.91 | +2,649.37% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.95 | +10,426.32% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.46 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.15 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $28.30 | +16.61% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $6.16 | +1,166.23% | 1 | Mar 24, 2017 |
Lexicon Pharmaceuticals
Mar 5, 2026
Maintains: Buy
Price Target: $4 → $6
Current: $1.72
Upside: +248.84%
Q32 Bio
Feb 25, 2026
Initiates: Buy
Price Target: $13
Current: $4.54
Upside: +186.34%
Ligand Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $231 → $239
Current: $201.35
Upside: +18.70%
Fortress Biotech
Feb 23, 2026
Reiterates: Buy
Price Target: $17
Current: $3.05
Upside: +457.38%
Armata Pharmaceuticals
Feb 23, 2026
Maintains: Buy
Price Target: $9 → $15
Current: $10.80
Upside: +38.89%
Adlai Nortye
Feb 13, 2026
Upgrades: Buy
Price Target: $16
Current: $8.66
Upside: +84.86%
Aprea Therapeutics
Jan 29, 2026
Maintains: Buy
Price Target: $5 → $4
Current: $0.93
Upside: +332.25%
CalciMedica
Jan 29, 2026
Downgrades: Neutral
Price Target: n/a
Current: $0.60
Upside: -
Tempest Therapeutics
Jan 22, 2026
Upgrades: Buy
Price Target: $11
Current: $2.35
Upside: +368.20%
Kura Oncology
Jan 13, 2026
Reiterates: Buy
Price Target: $40
Current: $8.25
Upside: +384.85%
Jan 9, 2026
Reiterates: Buy
Price Target: $240 → $310
Current: $257.15
Upside: +20.55%
Dec 22, 2025
Maintains: Buy
Price Target: $120 → $136
Current: $61.47
Upside: +121.25%
Dec 16, 2025
Initiates: Buy
Price Target: $12
Current: $2.40
Upside: +400.00%
Dec 12, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.74
Upside: +305.41%
Dec 11, 2025
Maintains: Buy
Price Target: $104 → $97
Current: $26.33
Upside: +268.40%
Dec 5, 2025
Maintains: Buy
Price Target: $21 → $7
Current: $4.60
Upside: +52.17%
Dec 3, 2025
Maintains: Buy
Price Target: $24 → $60
Current: $25.20
Upside: +138.10%
Dec 2, 2025
Reiterates: Buy
Price Target: $8
Current: $0.49
Upside: +1,521.73%
Dec 1, 2025
Upgrades: Buy
Price Target: $6
Current: $4.90
Upside: +22.45%
Nov 28, 2025
Reiterates: Buy
Price Target: $47
Current: $27.57
Upside: +70.48%
Nov 26, 2025
Reiterates: Buy
Price Target: $26
Current: $6.00
Upside: +333.33%
Nov 24, 2025
Maintains: Buy
Price Target: $9
Current: $1.87
Upside: +381.28%
Nov 13, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $0.65
Upside: +2,194.63%
Oct 29, 2025
Maintains: Buy
Price Target: $20 → $9
Current: $4.35
Upside: +107.13%
Oct 20, 2025
Assumes: Buy
Price Target: $52
Current: $29.74
Upside: +74.85%
Oct 8, 2025
Reiterates: Buy
Price Target: $57
Current: $29.51
Upside: +93.15%
Sep 29, 2025
Reiterates: Buy
Price Target: $102
Current: $30.73
Upside: +231.92%
Sep 22, 2025
Reiterates: Buy
Price Target: $25
Current: $1.20
Upside: +1,992.05%
Sep 19, 2025
Reiterates: Buy
Price Target: $16
Current: $2.90
Upside: +451.72%
Sep 15, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.90
Upside: -
Aug 21, 2025
Reiterates: Buy
Price Target: $15
Current: $4.23
Upside: +254.61%
Aug 20, 2025
Maintains: Buy
Price Target: $50 → $42
Current: $29.19
Upside: +43.88%
Aug 5, 2025
Maintains: Buy
Price Target: $5 → $30
Current: $30.73
Upside: -2.38%
Aug 4, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $9.05
Upside: +10.56%
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.58
Upside: -
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $29.09
Upside: +44.38%
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $1.16
Upside: +1,112.12%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.23
Upside: +225.20%
Jun 18, 2025
Reiterates: Buy
Price Target: $100
Current: $2.29
Upside: +4,266.81%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $3.15
Upside: +90.78%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $2.86
Upside: +809.09%
Jun 11, 2025
Reiterates: Buy
Price Target: $280
Current: $2.43
Upside: +11,422.63%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $1.02
Upside: +1,566.67%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $8.00
Upside: +300.00%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $0.16
Upside: +5,539.10%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.36
Upside: +1,223.53%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $5.77
Upside: +315.94%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.39
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $5.46
Upside: +467.77%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.63
Upside: +1,812.66%
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $15.63
Upside: +136.72%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.86
Upside: +491.40%
Feb 13, 2025
Maintains: Buy
Price Target: $17 → $7
Current: $21.70
Upside: -67.74%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $0.91
Upside: +2,649.37%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $0.95
Upside: +10,426.32%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.46
Upside: -
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.15
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $28.30
Upside: +16.61%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $6.16
Upside: +1,166.23%